Skip to main content
WCGIC 2023 Main banner
Back

Takayuki Yoshino, MD, PhD

National Cancer Center Hospital East, Japan
Kashiwa, Japan

Dr. Takayuki Yoshino, M.D., Ph.D., currently works at the National Cancer Center Hospital East in Chiba, Japan, where he is the Deputy Director of Hospital,
Head, Division for the Promotion of Drug and Diagnostic Development, and Chief for the Department of Gastrointestinal Oncology. Dr. Yoshino has a particular interest in chemotherapy for gastrointestinal cancers, especially for colorectal cancer, where he focuses on various investigational new agent and translational research regarding potential predictive and prognostic biomarkers. He received his medical degree from the National Defense Medical College and after completing his first residency there, he moved to the National Cancer Center East where he specialized in gastrointestinal oncology. Dr. Yoshino later spent five years at the Shizuoka Cancer Center and during this time, he studied in the USA for a year at several world-renowned institutions, including the Mayo Clinic, Dana-Farber Cancer Institute and the Vanderbilt-Ingram Cancer Center. In 2007 Dr. Yoshino returned to the National Cancer Center East, where he has held senior positions ever since. Dr. Yoshino has had over 300 peer-review scholar journal publications on CRC. In addition, he holds several professional appointments, serving on a Guidelines Steering Committee member of ESMO, a chair of Pan-Asian adapted ESMO Guideline for CRC, an advisory committee member of ASCO Breakthrough, the Vice President of JSCO and the administrative board & a chair of international affairs committee of JSMO. He was the first Japanese plenary speaker at ASCO 2022 Annual Meeting (5th /JUN/ 2022).

Presentation(s):